Health-Related Quality-Of-Life Results from the Phase 3 Optimismm Study: Pomalidomide, Bortezomib, and Low-Dose Dexamethasone Versus Bortezomib and Low-Dose Dexamethasone in Relapsed or Refractory Multiple Myeloma

AuthID
 P-00S-2A0
26
Author(s)
Moreau, P
·
Yagci, M
·
Larocca, A
·
Kanate, AS
·
Vural, F
·
[+2]·
[+4]·
Ben Yehuda, D
·
Guo, SE
·
Grote, L
·
Dhanasiri, S
·
Richardson, P
View all authors
Document Type
Article
Year published
2020
Published
in LEUKEMIA & LYMPHOMA, ISSN: 1042-8194
Volume: 61, Issue: 8, Pages: 1850-1859 (10)
Indexing
Wos®
Scopus®
Pubmed®
Google Scholar®
Publication Identifiers
Pubmed: 32268815
Scopus: 2-s2.0-85084198557
Wos: WOS:000558463800009
Source Identifiers
ISSN: 1042-8194
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.
All authors
Name Order Name   Name Order Name   Name Order Name
1 Weisel, K;   2 Dimopoulos, M;   3 Moreau, P;
4 Yagci, M;   5 Larocca, A;   6 Kanate, AS;
7 Vural, F;   8 Cascavilla, N;   9 Basu, S;
10 Johnson, P;   11 Byeff, P;   12 Hus, M;
13 Rodriguez Otero, P;   14 Muelduer, E;   15 Anttila, P;
16 Hayden, PJ;   17 Krauth, MT;   18 Lucio, P;
19 Ben Yehuda, D;   20 Mendeleeva, L;   21 Guo, SE;
22 Yu, X;   23 Grote, L;   24 Biyukov, T;
25 Dhanasiri, S;   26 Richardson, P;  

A place for researchers and their institutions

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service